Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
The race for the repurposing and development of treatments for COVID-19 continues amidst conflicting data on the new strain of coronavirus. Due to the shorter developmental times in comparison to…
SARS-CoV-2 is a new Betacoronavirus responsible for the COVID-19 respiratory outbreak. The virus is also the third of the genus… Read More
The ever-elusive cure for human immunodeficiency virus (HIV) infection continues to be out of reach for most patients. But the… Read More
Uniquely poised between research labs and the clinic, Professor Tomáš Kalina and his team at the Charles University in Prague,… Read More
Intrigued by how parasites are able to elude our immune system, Professor Richard Pleass from the Liverpool School of Tropical… Read More
Every year since 2014, at least 6 new monoclonal antibody therapies enter the clinic. These molecules are designed to target… Read More
The proportion of fully human monoclonal antibodies gaining clinical approval has quickly escalated since the approval of Humira® in 2002. Read More
Up to 2019, 79 antibodies were granted approval by the FDA or EMA for clinical use in the US or… Read More
Transformation or transfection are still considered one of the most challenging steps in recombinant antibody production. The choice of… Read More
Understanding what stimulates antibody production is important to improve the efficiency of both active and passive immunization strategies. Due to… Read More